Use of levodopa decarboxylase inhibitor

PDMED_LEVODOPA_DECARBOXYLASEINHIBITOR

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — N04BA02 1 out of 7 registries used, show all original rules.	5143
4. Check minimum number of events Min. number of events 3	5143
5. Include endpoints None	5143
6. Filter based on genotype QC (FinnGen only)	5143

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	PDMED_LEVODOPA_DECARBOXYLASEINHIBITOR
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	N04BA02
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Use of levodopa decarboxylase inhibitor based on the number of shared cases.

Similar with more cases:

Any prescribed medicine buy

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5143	2068	3075
Unadjusted period prevalence (%)	1.09	0.70	1.36
Median age at first event (years)	71.37	70.44	71.99

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4329: Matched controls
43288

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

+∞

323.0

4329

212

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

48.5

323.0

503

117

G20

ICD-10 Finland

Parkinson disease

928.1

323.0

3560

215

N04BC04

ATC

ropinirole; oral

224.6

323.0

935

N06DA03

ATC

rivastigmine; oral, transdermal

9.7

323.0

831

1033

N04BD02

ATC

rasagiline; oral

1263.0

323.0

821

N04BD01

ATC

selegiline; oral

404.8

323.0

1558

193

Kela drug reimbursment

Rasagiline

2048.0

323.0

668

N04BC09

ATC

rotigotine; transdermal

275.9

323.0

355

N87

ICPC

Parkinsonism

275.4

323.0

1336

N04BX02

ATC

entacapone; oral

4442.0

323.0

414

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

1367.4

323.0

3508

135

N04BC05

ATC

pramipexole; oral

16.7

323.0

1736

1667

F02.39*G20

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

587.4

323.0

520

N04BA03

ATC

levodopa, decarboxylase inhibitor and COMT inhibitor; oral

1274.0

323.0

1133

R25.1

ICD-10 Finland

Tremor, unspecified

16.2

323.0

681

494

N05AH04

ATC

quetiapine; oral

4.7

283.5

1131

3034

N03AE01

ATC

clonazepam; systemic

7.0

252.1

677

1117

AAG20

NOMESCO Finland

Stereotactic intracranial implantation of electrodes

334.9

193.0

194

N04BB01

ATC

amantadine; oral

15.6

189.4

320

220

G21.9

ICD-10 Finland

Secondary parkinsonism, unspecified

71.7

173.5

199

N04AA02

ATC

biperiden; systemic

12.6

153.3

284

240

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

4.5

148.5

586

1469

G04BD12

ATC

mirabegron; oral

3.3

146.7

854

2984

AEA50

NOMESCO Finland

Adjustment of implanted neurostimulator

103.5

136.9

150

F02.39

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

668.0

132.3

130

H02AA02

ATC

fludrocortisone; oral

17.2

131.5

213

130

C07AA05

ATC

propranolol; systemic

2.9

127.3

935

3794

R53

ICD-10 Finland

Malaise and fatigue

2.5

125.8

1244

6001

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

7.4

114.9

288

414

G23.9

ICD-10 Finland

Degenerative disease of basal ganglia, unspecified

81.2

111.8

126

AA5EN

NOMESCO Finland

Brain reseptor or transprot protein distribution isotope imaging

45.5

111.0

137

A28

ICPC

Limited function/disability NOS

2.4

104.6

1144

5719

AA1AD

NOMESCO Finland

CT of head and brain

2.2

103.7

1458

8198

SPAT1229

SPAT

Assessment of need for aid

3.0

102.3

673

2506

I95.1

ICD-10 Finland

Orthostatic hypotension

4.2

100.4

409

1040

N04BC02

ATC

pergolide; oral

261.3

100.1

102

XA800

NOMESCO Finland

Neuropsychological investigation

6.2

97.4

278

477

L28

ICPC

Limited function/disability (L)

2.3

94.8

1062

5331

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.1

93.7

1509

8898

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.0

91.8

1639

10055

XF606

NOMESCO Finland

Ortostatic test

13.5

90.6

161

123

N06AX11

ATC

mirtazapine; oral

2.1

90.2

1465

8640

A06AD11

ATC

lactulose; oral

2.3

89.5

1059

5433

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

3.3

86.9

480

1569

N04BC06

ATC

cabergoline; oral (dopamine agonists)

31.6

83.2

111

SPAT1216

SPAT

Assessment of functional ability

2.2

82.6

1021

5317

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.2

82.4

1031

5396

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.1

81.0

504

1787

3320A

ICD-9 Finland

Parkinson's disease, Paralysis agitans

122.3

78.2

G23.1

ICD-10 Finland

Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]

79.8

76.3

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

3.1

73.7

442

1525

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

7.7

71.8

172

230

G02CB01

ATC

bromocriptine; systemic

14.4

70.8

122

R1250

NOMESCO Finland

Evaluation of functional capability

6.7

69.0

183

284

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

26.5

68.8

N06AB10

ATC

escitalopram; oral

2.3

68.4

709

3361

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.2

68.0

837

4300

N03AX12

ATC

gabapentin; oral

2.2

66.1

765

3816

G21.8

ICD-10 Finland

Other secondary parkinsonism

56.7

66.0

N29

ICPC

Neurological sympt/complt other

5.7

65.6

197

359

G31.8

ICD-10 Finland

Other specified degenerative diseases of nervous system

15.5

65.3

109

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.1

64.9

396

1378

N05BA04

ATC

oxazepam; oral

1.9

63.1

1138

6788

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

5.1

62.4

206

419

SPAT1215

SPAT

Assessment of need for medical rehabilitation

3.6

62.2

302

886

G25.0

ICD-10 Finland

Essential tremor

4.5

61.5

230

534

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

61.2

1026

5947

R4130

NOMESCO Finland

Speech therapy

5.2

59.1

193

388

F02.30

ICD-10 Finland

Dementia in Parkinson's disease without additional symptoms

+∞

58.4

N19

ICPC

Speech disorder

7.3

58.1

144

203

SPAT1231

SPAT

Assessment of adjustments needed in living environment

4.3

57.2

225

548

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.9

53.1

885

5080

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.3

53.1

548

2567

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.4

49.8

459

2027

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.4

49.3

446

1953

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

47.4

759

4272

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.5

47.3

413

1773

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

11.0

47.1

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.6

46.4

219

627

N06AB04

ATC

citalopram; systemic

1.8

46.3

891

5348

D21

ICPC

Swallowing problem

5.6

45.9

139

256

SPAT1234

SPAT

Support of social functional capacity

2.6

45.9

366

1496

N28

ICPC

Limited function/disability (N)

4.7

44.9

158

345

N99

ICPC

Neurological disease other

6.8

44.2

114

171

G25.2

ICD-10 Finland

Other specified forms of tremor

11.6

43.5

Z2445

NOMESCO Finland

Psychologist

4.5

43.5

160

365

U04

ICPC

Incontinence urine

2.8

43.4

297

1106

A04

ICPC

Weakness/tiredness general

2.0

43.2

643

3510

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

41.4

1343

9368

S01.0

ICD-10 Finland

Open wound of scalp

2.3

41.3

420

1943

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.9

41.3

268

965

R35

ICD-10 Finland

Polyuria

2.4

41.3

384

1701

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.6

41.2

311

1229

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.5

38.3

319

1330

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.8

38.2

171

469

G23.8

ICD-10 Finland

Other specified degenerative diseases of basal ganglia

55.5

37.3

R47.1

ICD-10 Finland

Dysarthria and anarthria

6.1

36.8

103

173

G24.9

ICD-10 Finland

Dystonia, unspecified

15.1

36.6

F02.32

ICD-10 Finland

Dementia in Parkinson's disease other additional symptoms, mainly hallucinations

360.1

36.0

G90.3

ICD-10 Finland

Multi-system degeneration

35.7

35.9

K59.09

ICD-10 Finland

Constipation, unspecified

2.3

35.5

361

1667

S72.0

ICD-10 Finland

Fracture of neck of femur

2.4

33.8

294

1254

P20

ICPC

Memory disturbance

1.7

33.4

760

4752

130

Kela drug reimbursment

Malignant tumour

0.3

32.5

2571

M48.0

ICD-10 Finland

Spinal stenosis

1.8

32.1

658

3976

K59.0

ICD-10 Finland

Constipation

2.3

32.1

313

1415

M54.5

ICD-10 Finland

Low back pain

1.6

32.0

1156

8172

R13

ICD-10 Finland

Dysphagia

2.2

31.5

344

1640

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.0

31.5

189

648

N30.0

ICD-10 Finland

Acute cystitis

1.8

31.1

611

3642

N06AX21

ATC

duloxetine; oral

2.1

30.3

378

1908

N04BX04

ATC

opicapone; oral

+∞

30.2

SPAT1297

SPAT

Other function in accordance with speech therapy nomenclature

10.1

30.1

N02BE01

ATC

paracetamol; systemic, rectal

1.6

30.0

3509

31684

R60.0

ICD-10 Finland

Localized oedema

1.8

29.4

551

3229

N04BC07

ATC

apomorphine; parenteral

+∞

29.2

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

29.0

1058

7466

W19

ICD-10 Finland

Unspecified fall

1.9

28.6

435

2367

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.5

28.5

137

399

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.1

28.5

349

1744

S06.0

ICD-10 Finland

Concussion

1.9

28.4

422

2279

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

3.7

27.9

124

339

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.0

27.4

380

1998

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.9

27.3

458

2583

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.8

27.1

183

677

N04BC01

ATC

bromocriptine; oral

41.5

26.7

AA5QN

NOMESCO Finland

97.3

26.7

L03

ICPC

Low back symptom/complaint

1.6

26.6

855

5833

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.2

26.2

295

1423

R1260

NOMESCO Finland

Evaluation of communicative skills

3.6

26.2

122

347

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

26.2

666

4269

SPAT1053

SPAT

Memory test

1.6

26.1

890

6154

F0232, G20

ICD-10 Finland

+∞

26.1

R55

ICD-10 Finland

Syncope and collapse

1.7

25.9

560

3424

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

2.7

25.0

179

686

F0230, G20

ICD-10 Finland

+∞

25.0

N04AA01

ATC

trihexyphenidyl; oral

58.3

25.0

N06AX16

ATC

venlafaxine; oral

1.9

24.8

376

2044

YX8AD

NOMESCO Finland

Stereotactic CT examination for dose design of radiotherapy

24.4

24.3

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

4.2

23.9

227

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

3.8

23.8

101

267

N08

ICPC

Abnormal involuntary movements

12.5

23.5

N05AH03

ATC

olanzapine; systemic

2.5

23.4

186

757

SPAT1301

SPAT

No procedures

1.4

23.2

1338

10310

G04BD08

ATC

solifenacin; oral

1.9

23.2

365

2009

N05AX08

ATC

risperidone; systemic

1.9

22.8

369

2052

JDB10

NOMESCO Finland

Percutaneous gastrostomy

4.0

22.5

235

M03BX01

ATC

baclofen; systemic

4.0

22.4

236

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

22.0

333

1807

R42

ICD-10 Finland

Dizziness and giddiness

1.5

21.9

979

7157

N04BX01

ATC

tolcapone; oral

+∞

21.9

H50.52

ICD-10 Finland

Exophoria

7.0

21.9

G04BD11

ATC

fesoterodine; oral

2.5

21.8

173

705

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.1

21.8

258

1271

TAB00

NOMESCO Finland

Lumbar puncture

2.6

21.6

157

608

N06AX03

ATC

mianserin; oral

2.2

21.5

224

1045

XKD00

NOMESCO Finland

Uroflowmetry

1.5

21.2

879

6322

N03AG01

ATC

valproic acid; systemic, rectal

2.2

20.9

214

987

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

20.9

406

2399

R23

ICPC

Voice symptom/complaint

3.8

20.8

242

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

20.8

1645

13340

G04BD09

ATC

trospium; oral

2.7

20.8

148

566

N03AX16

ATC

pregabalin; oral

1.5

20.7

888

6421

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

4.8

20.7

145

AAW01

NOMESCO Finland

Implantation of intracranial stimulation device

77.1

20.7

S70.0

ICD-10 Finland

Contusion of hip

2.3

20.6

188

822

G23.2

ICD-10 Finland

Multiple system atrophy, parkinsonian type [MSA-P]

210.9

20.6

Z75.5

ICD-10 Finland

Holiday relief care

3.7

20.6

245

N05BA06

ATC

lorazepam; systemic, sublingual

2.1

20.4

246

1220

R32

ICD-10 Finland

Unspecified urinary incontinence

2.7

20.4

146

560

H02AB02

ATC

dexamethasone; systemic

0.4

20.4

116

2525

R41.0

ICD-10 Finland

Disorientation, unspecified

2.3

20.2

191

849

J01EA01

ATC

trimethoprim; systemic

1.4

20.1

1020

7628

R2110

NOMESCO Finland

Giving the first information

2.1

20.1

234

1144

N86

ICPC

Multiple sclerosis

8.7

20.1

SPAT1254

SPAT

Administration of medicine

1.5

20.0

689

4746

F02.34

ICD-10 Finland

Dementia in Parkinson's disease, other additional symptoms of mixed type

+∞

19.8

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

19.7

684

4718

N05AH02

ATC

clozapine; systemic

5.2

19.4

116

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.9

19.3

303

1666

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

4.5

19.3

152

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.6

19.3

139

537

M41.9

ICD-10 Finland

Scoliosis, unspecified

4.4

19.2

157

G04CA02

ATC

tamsulosin; oral

1.4

19.0

1284

10097

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.3

18.7

178

796

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

3.4

18.5

263

N06DA02

ATC

donepezil; oral

1.8

18.4

339

1967

R44.1

ICD-10 Finland

Visual hallucinations

6.6

18.4

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.7

18.4

413

2547

G24.8

ICD-10 Finland

Other dystonia

11.5

17.9

C01CA01

ATC

etilefrine; systemic

4.5

17.9

141

I95.9

ICD-10 Finland

Hypotension, unspecified

3.2

17.8

303

F02.31

ICD-10 Finland

Dementia in Parkinson's disease other additional symptoms, mainly paranoidism

+∞

17.7

R60.9

ICD-10 Finland

Oedema, unspecified

2.1

17.6

216

1080

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

0.6

17.5

222

3792

K02.1

ICD-10 Finland

Caries of dentine

1.3

17.3

1656

13721

G04BD04

ATC

oxybutynin; oral, transdermal

1.8

16.7

283

1596

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

16.5

508

3397

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.9

16.3

251

1369

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.2

16.2

910

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

6.4

16.2

C03CA01

ATC

furosemide; systemic

1.3

16.2

1601

13298

Z29

ICPC

Social problem NOS

3.2

16.1

270

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

16.1

772

5677

N05BA01

ATC

diazepam; systemic, rectal

1.5

16.1

520

3517

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.2

16.0

158

722

H50.31

ICD-10 Finland

Intermittent exotropia

6.9

15.9

F06.0

ICD-10 Finland

Organic hallucinosis

9.5

15.9

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

4.8

15.8

109

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

3.6

15.7

201

N30.9

ICD-10 Finland

Cystitis, unspecified

1.9

15.6

245

1347

UKC02

NOMESCO Finland

Cystoscopy

1.4

15.5

813

6077

G04BD07

ATC

tolterodine; oral

1.8

15.5

267

1517

Z50.5

ICD-10 Finland

Speech therapy

3.8

15.5

168

P29

ICPC

Psychological sympt/compl other

2.4

15.4

128

534

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.2

15.3

163

771

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

3.1

15.0

268

J01CA08

ATC

pivmecillinam; oral

1.3

14.9

1229

9901

N87

ICD-10 Finland

Dysplasia of cervix uteri

56.8

14.8

Z3226

NOMESCO Finland

Physiotherapist

1.4

14.5

695

5102

F02.3

ICD-10 Finland

Dementia in Parkinson disease

150.4

14.5

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.7

14.3

363

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

14.3

646

4688

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

2.6

14.2

104

408

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

6.8

14.2

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

9.1

14.2

SPAT1167

SPAT

Insertion of urinary catheter

1.9

14.1

192

1006

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

6.0

14.0

A03FA01

ATC

metoclopramide; systemic, rectal

0.7

13.9

402

5738

R33

ICD-10 Finland

Retention of urine

1.6

13.8

416

2763

S01.41

ICD-10 Finland

Open wound in the temple-jaw region

4.2

13.8

126

XKC03

NOMESCO Finland

Water cystometry

2.2

13.8

138

636

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

13.7

1177

9514

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

13.6

551

3907

G21.2

ICD-10 Finland

Secondary parkinsonism due to other external agents

140.4

13.4

N02AA05

ATC

oxycodone; systemic

1.4

13.3

673

4984

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

13.3

595

4307

L17

ICPC

Foot/toe symptom/complaint

1.4

13.1

909

7105

Z02.4

ICD-10 Finland

Examination for driving licence

0.7

13.0

696

8975

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.0

13.0

168

860

K11.72

ICD-10 Finland

Xerostomia

16.7

13.0

S01.8

ICD-10 Finland

Open wound of other parts of head

3.3

12.9

201

M41.4

ICD-10 Finland

Neuromuscular scoliosis

50.1

12.8

G72.8

ICD-10 Finland

Other specified myopathies

2.8

12.8

299

R5110

SPAT

2.3

12.7

122

550

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.0

12.6

157

794

N06AX26

ATC

vortioxetine; oral

2.1

12.6

136

649

SPAT1172

SPAT

Guidance concerning hydration

2.1

12.6

138

661

M04AA01

ATC

allopurinol; systemic

0.7

12.5

342

4938

S00.0

ICD-10 Finland

Superficial injury of scalp

2.5

12.5

375

F023, G20

ICD-10 Finland

+∞

12.5

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

12.4

435

2990

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

2.6

12.4

352

A29

ICPC

General symptom/complaint other

1.5

12.4

439

3026

N03AX09

ATC

lamotrigine; oral

2.5

12.4

397

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.0

12.3

148

740

R44.3

ICD-10 Finland

Hallucinations, unspecified

6.4

12.1

R25.8

ICD-10 Finland

Other and unspecified abnormal involuntary movements

8.7

12.0

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.8

11.9

194

1084

N02CA01

ATC

dihydroergotamine; nasal, systemic

6.0

11.9

WYA20

NOMESCO Finland

Home visit

2.4

11.9

397

N05BA12

ATC

alprazolam; oral

1.6

11.9

328

2133

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.4

11.8

419

AA1AA

NOMESCO Finland

Head X-ray examination

3.5

11.7

157

D12

ICPC

Constipation

2.0

11.7

154

796

SPAT1101

SPAT

Orthostatic test

1.7

11.6

232

1379

SPAT1050

SPAT

Extensive neurological examination

2.2

11.5

111

503

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

0.3

11.5

874

L01BC06

ATC

capecitabine; oral

0.3

11.5

738

F0234, G20

ICD-10 Finland

+∞

11.5

Z50.1

ICD-10 Finland

Other physical therapy

1.7

11.5

215

1257

L84

ICD-10 Finland

Corns and callosities

2.0

11.4

139

696

M79.6

ICD-10 Finland

Pain in limb

1.3

11.3

1190

9848

R4110

SPAT

2.2

11.3

110

503

SPAT1262

SPAT

Handing over of treatment supplies

1.4

11.3

752

5826

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.7

11.2

221

1312

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.5

11.2

375

2553

SPAT1240

SPAT

Therapeutic discussion

1.7

11.0

223

1331

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.1

11.0

123

597

N17

ICPC

Vertigo/dizziness

1.5

11.0

431

3037

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.0

10.9

129

643

N06DX01

ATC

memantine; oral

1.5

10.8

345

2321

F05.9

ICD-10 Finland

Delirium, unspecified

2.2

10.8

106

486

JX1LA

NOMESCO Finland

Kinetic X-ray of alimentary tract with pictures

12.9

10.6

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

3.8

10.5

114

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.9

10.5

145

766

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

10.5

243

1511

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.7

10.5

211

1259

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

14.2

10.5

R63.4

ICD-10 Finland

Abnormal weight loss

1.9

10.4

146

773

AAG99

NOMESCO Finland

Other stereotactic intracranial operation

+∞

10.4

H02AB06

ATC

prednisolone; systemic

0.8

10.4

1331

15466

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.3

10.4

410

R4110

NOMESCO Finland

Physiotherapy

1.3

10.2

949

7709

SPAT1304

SPAT

Counselling and guidance related to ageing

1.5

10.2

355

2439

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

0.3

10.2

744

WX290

NOMESCO Finland

Other blockade of nerve

1.3

10.1

1021

8377

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.1

10.1

112

543

G31.0

ICD-10 Finland

Circumscribed brain atrophy

5.0

10.1

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

10.1

576

4342

Y94.0

ICD-10 Finland

Accident at home

2.4

10.1

362

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.0

10.1

129

661

G25

ICD-10 Finland

Other extrapyramidal and movement disorders

14.6

10.0

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.2

10.0

1554

13440

G04CB02

ATC

dutasteride; oral

1.5

10.0

338

2308

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

10.0

403

2855

K90

ICPC

Stroke/cerebrovascular accident

1.9

9.9

146

788

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

2.6

9.9

278

L29

ICPC

Musculoskeletal sympt/complt other

1.6

9.9

267

1725

S01.9

ICD-10 Finland

Open wound of head, part unspecified

2.5

9.9

296

F03

ICD-10 Finland

Unspecified dementia

1.6

9.8

246

1561

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

3.1

9.8

175

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

9.8

499

3691

SPAT1360

SPAT

Extensive global examination

1.5

9.8

308

2066

N05CD07

ATC

temazepam; oral

1.4

9.8

584

4438

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

0.3

9.7

778

H53.2

ICD-10 Finland

Diplopia

2.0

9.7

122

622

K08.3

ICD-10 Finland

Retained dental root

1.6

9.7

248

1584

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.5

9.7

302

34200

ICD-8 Finland

Paralysis agitans, Parkinsonismus

55.1

9.6

Z11

ICPC

Compliance/being ill problem

4.0

9.6

RF120

NOMESCO Finland

2.9

9.5

196

ZXY02

NOMESCO Finland

Neuropsychologist

7.1

9.5

G21

ICD-10 Finland

Secondary parkinsonism

100.2

9.4

G23.3

ICD-10 Finland

Multiple system atrophy, cerebellar type [MSA-C]

100.2

9.4

G22

ICD-10 Finland

Parkinsonism in diseases classified elsewhere

+∞

9.4

NAG66

NOMESCO Finland

Posterior interbody fusion of lumbar spine, 2 vertebrae

5.3

9.3

N31.1

ICD-10 Finland

Reflex neuropathic bladder, not elsewhere classified

4.2

9.3

WX110

NOMESCO Finland

Local anesthesy

1.2

9.3

2186

19703

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

9.3

1811

16013

SPAT1263

SPAT

Sampling

1.2

9.3

1524

13231

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.3

9.2

739

5870

N06AA12

ATC

doxepin; systemic

1.7

9.2

202

1241

F21

ICPC

3.0

9.2

173

EBA00

NOMESCO Finland

Extraction of tooth

1.3

9.1

1007

8344

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.9

9.1

130

697

WF049

NOMESCO Finland

Radiotherapy of metastasis

0.4

9.1

753

M03AX01

ATC

botulinum toxin; parenteral

4.9

9.1

G24

ICD-10 Finland

Dystonia

15.6

9.0

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

9.0

353

2482

N31.8

ICD-10 Finland

Other neuromuscular dysfunction of bladder

4.7

9.0

P03

ICPC

Feeling depressed

1.8

9.0

159

918

R30.1

ICD-10 Finland

Vesical tenesmus

2.4

9.0

321

R27.0

ICD-10 Finland

Ataxia, unspecified

4.8

9.0

Z02.7

ICD-10 Finland

Issue of medical certificate

1.6

8.9

211

1324

SPAT1244

SPAT

Occupational therapy

2.8

8.9

194

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

2.1

8.9

102

503

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.3

8.8

318

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.3

8.8

606

4709

WF002

NOMESCO Finland

Radical radiotherapy

0.5

8.8

1372

R26

ICD-10 Finland

Abnormalities of gait and mobility

5.6

8.7

K56.2

ICD-10 Finland

Volvulus

3.6

8.7

103

W06

ICD-10 Finland

Fall involving bed

3.0

8.7

157

N30

ICD-10 Finland

Cystitis

1.6

8.6

211

1331

B03BA03

ATC

hydroxocobalamin; parenteral

1.5

8.6

271

1820

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.4

8.6

396

2875

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

0.2

8.5

406

A03FA02

ATC

cisapride; oral, rectal

1.5

8.5

323

2256

J01MA02

ATC

ciprofloxacin; systemic

1.2

8.5

1543

13508

G81.9

ICD-10 Finland

Hemiplegia, unspecified

2.9

8.5

176

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

0.3

8.5

531

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.4

8.5

461

3446

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

1.7

8.4

159

935

N06AB06

ATC

sertraline; oral

1.5

8.4

258

1723

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

3.6

8.4

101

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.3

8.4

581

4514

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

2.4

8.3

288

F01.29

ICD-10 Finland

Subcortical vascular dementia without information on additional symptoms

4.5

8.3

M40.1

ICD-10 Finland

Other secondary kyphosis

8.5

8.3

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

0.2

8.3

420

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.4

8.2

380

2761

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.7

8.2

147

852

N03AF02

ATC

oxcarbazepine; oral

2.0

8.2

102

521

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

4.1

8.1

G47.9

ICD-10 Finland

Sleep disorder, unspecified

2.3

8.1

297

SCA02

NOMESCO Finland

Analysis and advice of nutrition with regard to dentistry

1.5

8.1

237

1567

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.1

8.1

416

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

0.5

8.1

1383

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

8.1

276

1888

N05CF01

ATC

zopiclone; oral

1.2

8.1

1291

11138

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.1

8.0

398

TKC22

NOMESCO Finland

Catheterisation instruction

2.0

8.0

484

SPAT1293

SPAT

Other function in accordance with rehabilitation guidance nomenclature

3.8

8.0

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.4

8.0

326

2312

M41.5

ICD-10 Finland

Other secondary scoliosis

6.3

8.0

3AX01

NOMESCO Finland

5.5

8.0

359

Kela drug reimbursment

Mirabegroni

3.2

8.0

122

M43.1

ICD-10 Finland

Spondylolisthesis

1.8

7.9

124

688

K03.66

ICD-10 Finland

Tooth plaque

1.6

7.9

188

1181

N05AN01

ATC

lithium; oral

2.5

7.9

231

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.3

7.8

289

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.8

7.8

136

780

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.3

7.7

668

5353

AXX01

NOMESCO Finland

Memory assessment

45.0

7.7

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.4

7.7

383

2819

A01

ICPC

Pain general/multiple sites

1.5

7.7

260

1776

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.5

7.7

297

2088

E86

ICD-10 Finland

Volume depletion

1.8

7.7

116

638

A06AX04

ATC

linaclotide; oral

5.9

7.7

N06AA06

ATC

trimipramine; systemic

2.1

7.7

373

L76

ICPC

Fracture: other

1.9

7.6

106

566

U02

ICPC

Urinary frequency/urgency

1.4

7.6

424

3180

M05BA04

ATC

alendronic acid; oral

1.4

7.6

355

2582

N31.0

ICD-10 Finland

Uninhibited neuropathic bladder, not elsewhere classified

4.4

7.6

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

1.9

7.6

103

545

N03AA03

ATC

primidone; oral

6.7

7.6

G24.1

ICD-10 Finland

Idiopathic familial dystonia

25.0

7.6

U07

ICPC

Urine symptom/complaint other

1.5

7.5

215

1412

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.8

7.5

128

731

S22.3

ICD-10 Finland

Fracture of rib

1.5

7.5

243

1644

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.2

7.5

1136

9727

N05AX12

ATC

aripiprazole; systemic

2.5

7.5

210

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

7.5

575

4533

U05

ICPC

Urination problems other

1.6

7.5

191

1225

L86

ICPC

Back syndrome with radiating pain

1.6

7.4

176

1106

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.1

7.4

388

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.4

7.3

355

2602

N04C02

ATC

+∞

7.3

R03BB04

ATC

tiotropium bromide; inhalant

0.7

7.3

243

3390

N88

ICPC

Epilepsy

4.1

7.3

M54.3

ICD-10 Finland

Sciatica

1.6

7.3

178

1130

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

0.6

7.2

132

2067

S20.2

ICD-10 Finland

Contusion of thorax

1.6

7.2

161

998

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.5

7.1

214

S01

ICD-10 Finland

Open wound of head

2.5

7.1

215

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.5

7.1

205

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.2

7.1

294

EBA30

NOMESCO Finland

Excision of root of tooth

1.6

7.1

190

1236

RF433

NOMESCO Finland

10.0

7.0

SCA03

NOMESCO Finland

Preventive oral health care, extensive

1.8

7.0

103

563

M54

ICD-10 Finland

Dorsalgia

1.4

7.0

298

2135

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.8

7.0

121

695

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.5

6.9

255

1774

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

2.0

6.9

393

UDQ42

NOMESCO Finland

Endoscopic assessment of swallowing function

5.1

6.9

AA052

NOMESCO Finland

13.8

6.9

K88

ICPC

Postural hypotension

2.6

6.9

171

Z73.6

ICD-10 Finland

Limitation of activities due to disability

2.8

6.8

142

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.6

6.8

155

965

SDA02

NOMESCO Finland

Parodonthologic therapy

1.2

6.8

885

7453

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.8

6.8

108

606

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

0.7

6.8

233

3234

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

2.9

6.8

136

N06AB03

ATC

fluoxetine; oral

1.4

6.7

340

2509

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

1.9

6.7

473

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

2.9

6.7

127

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.1

6.7

333

R39.1

ICD-10 Finland

Other difficulties with micturition

1.8

6.7

117

674

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.5

6.7

199

F06.2

ICD-10 Finland

Organic delusional [schizophrenia-like] disorder

7.2

6.7

M01AC06

ATC

meloxicam; systemic, rectal

1.2

6.7

1203

10466

TJD20

NOMESCO Finland

Change of gastrostomy tube

4.1

6.7

A04AA55

ATC

palonosetron, combinations; systemic

0.2

6.7

312

G35

ICD-10 Finland

Multiple sclerosis

3.0

6.6

117

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

1.9

6.6

455

A02BC01

ATC

omeprazole; systemic

1.2

6.6

1058

9097

G25.3

ICD-10 Finland

Myoclonus

7.8

6.6

E87.6

ICD-10 Finland

Hypokalaemia

1.8

6.6

114

656

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.4

6.6

318

2333

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.6

6.6

169

1088

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

2.4

6.6

214

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

3.1

6.6

107

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

0.2

6.5

305

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.3

6.4

552

4413

N05AA02

ATC

levomepromazine; systemic

1.7

6.4

123

728

R21

NOMESCO Finland

Counselling and guidance in rehabilitation

2.8

6.4

136

K07

ICPC

Swollen ankles/oedema

1.5

6.4

189

1256

3010

Kela drug reimbursment

Midodrine

69.9

6.4

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.2

6.4

1544

13784

3339X

ICD-9 Finland

Other extrapyramidal disease and abnormal movement disorders, Other and unspecified extrapyramidal diseases and abnormal movement disorders

14.3

6.4

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.4

6.4

328

2433

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

6.4

503

3980

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

0.1

6.3

238

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

2.3

6.3

224

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.5

6.3

195

1308

207

Kela drug reimbursment

Chronic arrhythmias

0.8

6.3

464

5788

G24.3

ICD-10 Finland

Spasmodic torticollis

2.9

6.3

116

A04AA02

ATC

granisetron; systemic, transdermal

0.6

6.3

1248

F34.1

ICD-10 Finland

Dysthymia

2.0

6.3

373

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

5.5

6.3

R07.4

ICD-10 Finland

Chest pain, unspecified

1.2

6.3

1006

8644

WZA90

NOMESCO Finland

Other doctors statement

1.3

6.3

629

5130

RF420

NOMESCO Finland

2.4

6.3

218

J01DB01

ATC

cefalexin; oral

1.2

6.2

2939

27734

F0289, G318

ICD-10 Finland

26.7

6.2

NOMESCO Finland

Guidance supporting rehabilitation

26.7

6.2

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.4

6.2

208

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

6.2

2043

18713

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.2

6.2

723

6008

A08

ICPC

Swelling

1.6

6.2

163

1056

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.2

6.2

1096

9508

WZA10

NOMESCO Finland

Long statement of health and health related matters

2.8

6.2

128

L75

ICPC

Fracture: femur

2.1

6.1

286

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

1.9

6.1

441

SPAT1138

SPAT

Guidance concerning bowel function

2.1

6.1

288

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

0.4

6.1

654

N06AX12

ATC

bupropion; oral

1.9

6.1

443

SPAT1139

SPAT

Nutrition survey

1.7

6.1

118

704

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

0.7

6.1

134

2016

NF1AA

NOMESCO Finland

Hip X-ray examination

1.4

6.1

347

2618

G21.0

ICD-10 Finland

Malignant neuroleptic syndrome

8.6

6.0

SPAT1260

SPAT

Consultation of another employee

1.3

6.0

616

5036

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

0.2

6.0

273

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

6.0

1201

10527

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

0.2

6.0

250

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

3.3

6.0

SPAT1042

SPAT

Guidance concerning balance maintenance

3.0

6.0

103

M54.1

ICD-10 Finland

Radiculopathy

1.7

6.0

112

660

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

104

11.15

98.08

1.9

1.2

nmol/l

122.3

138.9

0.31

(3026008) Bacteria identified in Urine by Culture

2135

14551

1.80

86.59

4.3

3.5

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2028

14075

1.73

73.82

2.6

2.2

u/l

225.8

215.6

0.24

1899

13068

(3019309) Folate [Moles/volume] in Red Blood Cells

1552

10463

1.69

59.87

1.9

1.8

nmol/l

1171.0

1165.0

0.09

1190

7691

(3031040) Bacteria [#/volume] in Urine by Automated count

3434

28514

1.62

54.21

6.7

5.1

e6/l

2322.4

2212.5

0.03

489

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2528

19708

1.56

51.14

2.3

2.1

pmol/l

87.7

92.7

7.08

1516

10214

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2834

23214

1.49

41.75

5.5

6.9

mmol/l

1.2

0.86

2400

19397

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

224

850

2.71

40.74

1.3

1.2

mg/l

518.7

568.3

0.74

215

793

(3021960) Folate [Moles/volume] in Serum or Plasma

1599

11813

1.51

38.15

1.7

1.6

nmol/l

18.1

20.1

6.55

1406

9944

(3023368) Bacteria identified in Blood by Culture

1832

14008

1.48

36.52

4.2

4.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1403

10276

1.50

34.11

1.8

1.7

pmol/l

410.5

26531041.0

6.37

1161

8232

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2563

21107

1.43

33.38

5.1

6.1

mmol/l

1.2

0.18

2301

18878

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1173

8326

1.53

32.92

2.0

1.9

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

186

719

2.65

32.62

1.4

e6/l

708.0

1196.1

0.41

166

591

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

186

719

2.65

32.62

1.3

e6/l

3.7

25.2

1.83

156

558

(3044290) Cell count panel - Cerebral spinal fluid

177

669

2.70

32.45

1.3

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

186

740

2.57

30.78

1.3

1.2

mmol/l

3.8

3.9

0.64

175

681

(3037467) Urinalysis macro (dipstick) panel - Urine

3318

28827

1.43

30.75

5.7

4.8

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

105

319

3.34

28.31

1.0

ng/l

271.7

330.3

1.43

204

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

105

320

3.33

28.17

1.0

ng/l

32.1

46.3

4.19

201

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

105

321

3.32

28.03

1.0

ng/l

639.9

667.8

0.28

198

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

843

5760

1.55

27.58

1.9

1.8

—

(3035350) Ketones [Presence] in Urine by Test strip

2399

19952

1.38

27.26

5.1

4.1

estimate

0.0

0.00

438

3716

(3018418) pH of Serum or Plasma

1741

13744

1.40

27.01

3.2

4.1

7.4

2.21

296

2609

(3015736) pH of Urine

1952

15724

1.39

26.81

4.6

3.8

—

5.9

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

832

5722

1.54

26.32

1.9

1.8

—

(3030467) Casts [#/volume] in Urine by Automated count

1647

12974

1.40

25.53

3.8

3.4

e6/l

0.4

0.5

1.03

1304

9956

(3009261) Glucose [Presence] in Urine by Test strip

2413

20238

1.36

25.28

5.2

4.1

estimate

0.0

1.08

435

3628

(3006653) Thiamine [Moles/volume] in Blood

174

4.01

24.51

1.1

1.2

nmol/l

128.4

142.7

1.54

174

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2194

18208

1.36

24.24

4.7

4.3

ng/l

47.1

94.2

1.24

1756

14294

(3021601) Nitrite [Presence] in Urine by Test strip

2377

19975

1.35

24.18

6.9

5.4

estimate

0.0

0.00

435

3733

(3002582) Erythrocytes [#/volume] in Urine

1769

14200

1.37

24.12

4.0

3.5

e6/l

95.4

103.9

0.08

1407

11111

(3013826) Glucose [Moles/volume] in Serum or Plasma

2996

26114

1.35

23.78

5.0

4.8

mmol/l

6.6

6.9

10.06

2855

24563

(36304419) Bacteria [Presence] in Urine

1571

12395

1.39

23.72

3.8

3.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

234

3.50

23.67

1.1

nmol/l

1.5

8.4

—

(3018095) Leukocytes [#/volume] in Urine

1953

15962

1.36

23.62

4.5

4.0

e6/l

175.7

117.3

0.83

1481

11795

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1864

15225

1.35

22.26

5.7

4.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

499

3185

1.63

21.51

2.0

1.7

—

(3019150) Specific gravity of Urine by Refractometry

1181

9024

1.40

21.16

5.6

4.6

kg/l

1.0

1.21

192

1459

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1542

12345

1.36

20.61

2.3

mg/l

3.0

3.1

1.74

1273

10405

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

464

2942

1.63

20.51

1.5

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

2354

20097

1.32

20.02

3.8

4.8

g/l

34.7

34.4

1.15

2149

18458

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1056

7983

1.41

19.98

3.3

3.0

e6/l

1.4

1.2

0.45

639

4717

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3206

28622

1.32

19.45

4.0

3.9

pmol/l

15.5

15.1

13.87

2843

25223

(3000850) Epithelial cells [#/volume] in Urine

1278

10140

1.35

17.58

3.0

2.7

e6/l

4.9

4.6

0.41

1133

8880

(3029937) Albumin [Presence] in Urine by Test strip

1382

11144

1.33

16.92

5.6

4.5

estimate

0.0

0.69

414

3517

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1917

16211

1.29

16.41

2.8

2.9

ug/l

146.1

162.6

1.97

1689

14582

(3011397) Hemoglobin [Presence] in Urine by Test strip

1231

9801

1.34

16.35

4.8

4.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2076

17771

1.28

16.03

2.5

2.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

266

2.85

15.69

2.9

2.3

—

(3016018) Differential panel - Cerebral spinal fluid

335

2.62

15.55

1.2

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

274

2.80

15.43

1.1

1.2

mmol/l

1.9

2.1

2.30

255

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

963

7477

1.35

14.95

3.5

3.2

e6/l

2.2

2.1

0.24

549

4251

(3026782) Osmolality of Urine

1186

9527

1.32

14.55

3.4

2.9

mosm/kgh2o

576.5

551.0

3.98

1027

8085

(3015377) Calcium [Moles/volume] in Serum or Plasma

1820

15461

1.27

14.52

2.4

3.4

mmol/l

2.3

3.14

1528

13097

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

257

2.79

14.33

1.0

mg/l

270.9

285.2

1.02

226

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

347

2.50

14.01

1.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1240

14989

0.77

13.51

3.7

4.0

mg/mmol

7.2

9.8

1.99

804

9499

(3009508) Creatinine [Moles/volume] in Urine

1179

14336

0.77

13.43

2.9

3.2

mmol/l

7.5

7.2

1.67

946

11718

(3014271) Vancomycin [Susceptibility]

331

2.50

13.37

4.3

2.9

—

(40761535) Cells panel - Urine sediment

553

3983

1.44

13.35

3.8

3.7

—

(3012516) Albumin [Mass/volume] in Urine

1166

14181

0.77

13.27

3.0

3.3

mg/l

444.5

311.2

0.42

767

9085

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1122

9057

1.31

13.09

2.6

3.2

mmol/l

2.4

2.5

7.08

959

7864

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

278

1735

1.64

13.06

1.9

2.2

ug/l

532.2

617.1

0.15

251

1649

(3008152) Bicarbonate [Moles/volume] in Arterial blood

468

3290

1.46

12.84

5.4

6.8

mmol/l

25.8

24.5

12.21

434

3068

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1929

16721

1.25

12.38

2.2

nmol/l

76.6

79.8

5.20

1649

14460

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

182

2.93

11.84

1.2

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

821

10328

0.76

11.78

1.5

1.6

mmol/l

1.2

1.3

4.52

674

8496

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3766

35214

1.26

11.63

5.1

4.8

mu/l

1.9

2.1

3.68

3383

31179

(3019060) Gas panel - Arterial blood

483

3494

1.42

11.34

3.7

4.6

—

(3003396) Base excess in Arterial blood by calculation

755

5895

1.33

11.01

4.9

6.6

mmol/l

1.8

1.1

5.49

623

4513

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

332

2249

1.51

10.95

2.3

2.4

au/ml

27.1

22.9

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

303

2018

1.53

10.82

1.3

au/ml

93.0

60.8

0.81

(3027801) Oxygen [Partial pressure] in Arterial blood

755

5909

1.33

10.82

4.9

6.6

kpa

11.9

0.03

712

5589

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

755

5911

1.32

10.79

4.9

6.6

kpa

5.2

5.1

3.07

714

5593

(3023410) Appearance of Cerebral spinal fluid

300

2.39

10.57

1.4

1.3

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

311

2.33

10.22

1.1

—

3.3

—

(3013707) Erythrocyte sedimentation rate by Westergren method

3228

29894

1.21

9.88

3.9

4.3

mm/h

12.9

14.8

9.76

2937

27137

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

193

2.66

9.58

1.2

1.1

mg/l

362.5

317.5

0.18

164

(3009466) Valproate [Moles/volume] in Serum or Plasma

102

527

1.95

9.20

4.7

3.9

umol/l

367.5

341.9

0.89

439

(4034850)

205

1300

1.60

9.11

12.9

12.3

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

205

2.55

9.03

1.3

1.1

mg/l

54.1

47.4

0.19

171

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3482

36881

0.83

8.83

4.2

4.8

mmol/l

1.4

0.06

3085

32783

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

403

5393

0.73

8.58

2.6

4.0

ug/l

12.4

23.5

0.75

314

4503

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3360

35662

0.83

8.47

3.8

4.3

mmol/l

1.2

1.3

21.70

2938

31362

(3043409) Potassium [Moles/volume] in Arterial blood

233

1549

1.53

8.45

3.1

4.1

mmol/l

3.8

3.9

1.72

219

1437

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1029

8633

1.24

8.27

1.7

mg/l

1.4

1.5

0.87

822

6765

(3007853) Bacteria identified in Skin by Aerobe culture

647

5144

1.29

8.16

1.9

1.8

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

247

2.32

8.11

1.1

—

(3022621) pH of Urine by Test strip

400

2970

1.38

8.06

4.3

3.3

—

(3016502) Oxygen saturation in Arterial blood

666

5324

1.29

8.05

5.2

6.8

95.2

95.3

0.18

636

5108

(4035726)

278

3914

0.69

7.99

1.2

1.4

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

182

2.54

7.97

1.1

—

(1761868) Lipid panel - Serum or Plasma

855

10261

0.80

7.94

3.2

3.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4072

38882

1.23

7.92

21.0

18.0

mg/l

27.5

27.6

0.07

3532

32012

(3032080) INR in Blood by Coagulation assay

2224

20139

1.18

7.92

10.2

11.5

inr

1.3

1.4

4.39

578

5450

(3041096) Erythrocytes [Presence] in Urine by Automated

1195

10227

1.22

7.89

5.2

3.8

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

208

2.42

7.80

1.6

1.4

u/l

5.7

6.5

0.27

178

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

467

3578

1.34

7.68

1.7

1.6

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3539

37262

0.84

7.51

4.3

4.8

mmol/l

4.3

4.4

6.06

3157

33414

(3002173) Hemoglobin [Mass/volume] in Arterial blood

604

4819

1.29

7.39

5.5

7.3

g/l

121.3

119.7

1.16

581

4643

(3036481) Cortisol [Moles/volume] in Serum or Plasma

450

3463

1.33

7.19

1.8

2.2

nmol/l

389.5

377.7

0.57

399

3143

(3018405) Lactate [Moles/volume] in Arterial blood

261

1846

1.44

7.00

3.1

3.9

mmol/l

1.2

1.4

4.27

253

1813

(3020891) Body temperature

282

2044

1.40

6.61

4.0

4.7

—

(40768804) Tissue Pathology biopsy report

1444

16236

0.85

6.55

2.1

2.3

—

(4027681)

134

2.62

6.53

1.5

1.2

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

314

2329

1.37

6.41

2.6

2.5

0.7

1.18

299

2229

(3020630) Protein [Mass/volume] in Serum or Plasma

551

4431

1.27

6.32

1.9

2.5

g/l

66.3

65.9

0.61

469

3951

(3024354) Oxygen [Partial pressure] in Venous blood

497

3954

1.28

6.22

3.1

3.0

kpa

4.5

0.29

480

3800

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

322

2410

1.36

6.22

4.4

4.0

48.1

47.1

0.33

316

2376

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

180

2.34

6.21

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3678

38409

0.85

6.12

4.8

5.5

mmol/l

2.5

5.80

3256

34280

(3012095) Magnesium [Moles/volume] in Serum or Plasma

892

7592

1.21

6.07

2.2

3.0

mmol/l

0.8

2.09

813

7008

(3014576) Chloride [Moles/volume] in Serum or Plasma

744

6233

1.23

5.93

5.0

6.4

mmol/l

104.6

104.3

0.92

722

6081

(3019198) Lymphocytes [#/volume] in Blood

2232

20539

1.15

5.83

5.1

5.6

e9/l

1.7

1.9

2.21

1922

17659

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2136

19601

1.15

5.78

4.0

4.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1082

9415

1.19

5.77

4.5

4.2

ng/l

127.0

489.5

3.47

919

8235

(3001604) Monocytes [#/volume] in Blood

2185

20091

1.15

5.74

4.9

5.5

e9/l

0.6

16.88

1849

16990

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

700

5850

1.23

5.70

9.1

8.5

—

(3006315) Basophils [#/volume] in Blood

2196

20227

1.15

5.58

4.9

5.5

e9/l

0.0

13.79

1857

17132

(3000492) Spirometry study

223

3057

0.72

5.53

1.5

1.6

—

(3004588) Protein electrophoresis panel - Serum or Plasma

462

3709

1.27

5.39

1.9

2.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

233

3145

0.73

5.25

1.4

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1438

0.61

5.24

1.8

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

270

3562

0.74

5.23

1.3

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.76

5.19

1.0

1.1

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3409

32473

1.15

5.06

5.8

7.8

u/l

79.8

81.7

1.14

3154

30294

(3027273) Bicarbonate [Moles/volume] in Venous blood

336

2614

1.31

5.02

3.5

3.3

mmol/l

25.5

25.2

1.32

321

2534

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.63

4.97

1.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

162

1123

1.46

4.94

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

162

1123

1.46

4.94

1.4

1.3

—

(3044640) Blood type and Crossmatch panel - Blood

1541

13951

1.15

4.83

2.4

2.6

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

188

2.14

4.83

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.99

4.82

2.4

2.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.99

4.82

2.4

2.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.64

4.81

1.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

392

3130

1.27

4.80

3.1

3.2

g/l

126.8

126.9

0.05

381

3052

(3017143) Hepatitis C virus Ab [Presence] in Serum

227

3032

0.74

4.80

1.5

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

101

2.58

4.79

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

285

2186

1.32

4.74

4.8

5.0

1.5

1.6

1.61

272

2049

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

244

1.98

4.72

1.4

2.0

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1512

13699

1.15

4.66

2.3

2.6

u/l

54.9

58.8

2.95

1388

12546

(3007930) Methemoglobin/Hemoglobin.total in Blood

281

2158

1.32

4.64

4.8

5.0

0.9

0.82

269

2025

(40768793) Breast Pathology biopsy report

758

0.50

4.58

1.4

1.3

—

(3013115) Eosinophils [#/volume] in Blood

2241

20855

1.13

4.56

5.1

5.7

e9/l

0.2

7.99

1938

17891

(3033658) Prothrombin time (PT) actual/Normal

1212

10826

1.16

4.55

3.8

4.1

83.3

83.6

0.15

1179

10574

(3026493) Urate [Moles/volume] in Serum or Plasma

1036

11678

0.86

4.54

2.3

2.9

umol/l

8606.3

6236.5

0.67

833

9818

(3024869) Neuronal Ab [Presence] in Serum

2.65

4.48

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

906

0.55

4.44

1.6

1.5

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

572

4819

1.21

4.30

3.2

3.6

kpa

5.8

0.04

551

4658

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.53

4.29

1.1

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

389

3151

1.25

4.25

5.7

8.1

0.7

2.49

384

3123

(3033705) Calcium.ionized [Moles/volume] in Venous blood

110

730

1.52

4.21

2.7

2.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.42

4.18

1.1

1.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

433

1.67

4.16

2.5

2.0

u/field

1.8

1.6

0.12

148

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

587

4976

1.20

4.14

4.8

3.8

—

(3041354) Potassium [Moles/volume] in Venous blood

111

743

1.50

4.09

2.7

2.4

mmol/l

4.1

0.72

111

734

(3035285) Chloride [Moles/volume] in Venous blood

111

743

1.50

4.09

2.7

2.4

mmol/l

106.5

105.6

1.15

111

734

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

284

0.32

4.05

1.1

1.0

—

(3002032) Base excess in Venous blood by calculation

567

4802

1.20

4.04

3.2

3.6

mmol/l

2.6

1.9

4.63

476

3856

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

389

3171

1.25

4.03

5.6

7.9

1.3

0.05

383

3146

(3052851) Hemolysis interference index of Serum or Plasma

190

1412

1.36

3.96

3.6

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

516

4345

1.21

3.91

4.7

6.1

mmol/l

1.3

1.4

1.37

497

4156

(3027945) Reticulocytes/100 erythrocytes in Blood

725

6313

1.17

3.76

1.8

2.4

1.6

1.8

3.98

619

5507

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.34

3.75

1.2

1.1

—

(40768800) Prostate Pathology biopsy report

1312

0.66

3.73

1.1

1.2

—

(3022948) Iron [Moles/volume] in Serum or Plasma

865

7657

1.16

3.62

2.2

2.6

umol/l

11.5

12.0

1.59

770

7011

(3012544) pH of Venous blood

581

4983

1.19

3.61

3.2

3.6

7.4

—

(4281824)

401

0.40

3.60

1.3

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

206

1575

1.32

3.58

1.3

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

852

7542

1.16

3.56

2.0

29.9

30.2

0.77

825

7296

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

994

0.62

3.53

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

136

979

1.40

3.48

1.7

2.4

umol/l

26.6

34.2

3.57

105

806

(3003327) Ova and parasites identified in Stool by Light microscopy

134

967

1.40

3.39

1.6

—

(3047181) Lactate [Moles/volume] in Blood

202

1555

1.31

3.37

5.2

6.1

mmol/l

1.2

1.3

2.30

184

1383

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

253

2008

1.27

3.34

2.0

1.8

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

243

1922

1.28

3.30

2.5

3.2

pmol/l

4.3

0.13

201

1649

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

787

6965

1.15

3.30

1.2

u/ml

1.4

1.7

0.40

192

1691

(3037522) Nuclear Ab [Titer] in Serum

379

4530

0.82

3.28

1.3

titre

476.1

503.5

0.13

1023

(3004809) Band form neutrophils/100 leukocytes in Blood

863

0.61

3.25

2.3

3.7

3.3

1.5

0.69

640

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.78

3.25

1.1

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

270

2170

1.26

3.22

2.0

—

(3006270) Folate [Moles/volume] in Blood

429

1.57

3.11

1.2

nmol/l

330.6

321.1

0.14

332

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1070

0.66

3.10

2.9

2.6

mg/l

1.7

1.8

0.42

942

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

136

1827

0.74

3.10

2.2

3.3

u/ml

572.7

3419.5

1.08

107

1549

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1729

16116

1.11

3.08

2.9

3.2

ng/l

1587.2

1881.6

1.23

1482

14070

(3028026) IgM [Mass/volume] in Serum or Plasma

172

2232

0.76

3.07

1.7

1.9

g/l

1.7

1.4

0.47

150

1980

(3007566) Smooth muscle Ab [Titer] in Serum

935

0.64

3.07

1.2

1.1

titre

291.4

91.8

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

546

0.53

3.05

1.0

—

(3018572) Chloride [Moles/volume] in Blood

151

1134

1.34

3.02

5.7

6.8

mmol/l

105.5

105.1

0.54

138

1016

(3039000) Anion gap in Blood

151

1134

1.34

3.02

5.7

6.8

mmol/l

10.2

11.3

3.31

138

1016

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.75

2.98

1.1

1.2

—

(4024509)

498

1.51

2.97

1.6

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

551

4785

1.17

2.97

2.4

ug/l

6.0

7.0

0.96

408

4080

(21494755) Public health laboratory ask at order entry panel

986

0.65

2.94

1.5

1.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

501

1.50

2.90

1.5

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

370

3117

1.20

2.85

3.1

3.7

mmol/l

2.3

1.9

1.51

268

2268

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

275

2249

1.24

2.85

1.9

ug/l

2.3

2.4

0.05

223

1938

(3030981) Hyaline casts [#/volume] in Urine by Automated count

320

2662

1.22

2.81

3.1

2.9

e6/l

0.3

0.27

312

2616

(3003338) MCHC [Mass/volume]

3144

30265

1.10

2.81

27.0

24.0

g/l

330.9

331.3

1.44

3089

29909

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

144

1.95

2.79

1.1

1.0

u/l

1.0

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

669

0.59

2.79

1.1

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2471

23525

1.10

2.78

6.6

8.7

e9/l

4.4

0.12

2121

20308

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1181

0.70

2.73

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1143

0.70

2.69

1.5

—

(3028717) Thiamine [Mass/volume] in Blood

2.98

2.69

1.2

—

(3018010) Neutrophils/100 leukocytes in Blood

2018

19057

1.10

2.67

5.2

5.7

60.5

58.8

8.20

1839

17551

(4010399)

244

2981

0.81

2.67

1.4

—

(3022096) Basophils/100 leukocytes in Blood

1961

18497

1.10

2.66

5.1

5.8

0.6

7.71

1787

17031

(3003694) ABO and Rh group [Type] in Blood

1062

9712

1.12

2.65

1.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3572

36753

0.91

2.60

6.3

6.8

mmol/mol

40.3

41.1

6.12

3203

33133

(3006184) Hemoglobin [Mass/volume] in Capillary blood

152

1172

1.31

2.59

2.1

2.2

g/l

126.5

127.2

0.14

123

843

(3019550) Sodium [Moles/volume] in Serum or Plasma

4200

41090

1.12

2.58

24.8

21.6

mmol/l

139.7

139.6

3.68

4099

39923

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.90

2.58

1.7

1.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

384

3280

1.18

2.56

3.1

3.7

kpa

5.2

5.1

0.82

347

2993

(3009343) pH of Capillary blood

379

3235

1.19

2.55

3.2

3.7

7.4

2.46

402

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

7.15

2.55

1.0

1.1

—

(3000330) Specific gravity of Urine by Test strip

304

2549

1.20

2.50

5.0

3.8

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

203

1638

1.25

2.42

2.1

2.2

g/l

38.4

37.2

2.52

165

1365

(3023103) Potassium [Moles/volume] in Serum or Plasma

4203

41157

1.12

2.42

24.8

21.7

mmol/l

4.0

12.34

4098

39933

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3532

36318

0.91

2.42

19.0

17.3

ml/min/173m2

77.1

71.5

53.81

3000

30153

(3002030) Lymphocytes/100 leukocytes in Blood

2044

19381

1.09

2.41

5.4

6.0

24.6

25.7

4.52

1838

17744

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

0.00

2.40

0.0

1.2

—

115.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

147

1876

0.78

2.38

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

175

1.78

2.37

1.9

1.5

u/l

5.2

47.0

1.49

(42870588) Differential panel, method unspecified - Blood

1540

14430

1.10

2.36

4.8

5.6

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

358

0.50

2.32

1.4

1.5

—

(3006504) Eosinophils/100 leukocytes in Blood

2003

19001

1.09

2.31

5.1

5.8

2.7

2.8

3.08

1826

17475

(3033799) Differential panel - Peritoneal fluid

155

0.32

2.27

2.0

1.8

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

787

7140

1.12

2.26

2.2

2.6

g/l

2.2

2.3

0.23

699

6538

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

453

3966

1.16

2.25

3.4

4.0

mmol/l

1.2

0.43

387

3454

(3019069) Monocytes/100 leukocytes in Blood

2010

19090

1.09

2.24

5.4

6.1

8.6

9.0

9.00

1835

17608

(3024891) Influenza virus A+B Ag [Presence] in Specimen

118

899

1.32

2.23

1.3

1.2

—

(40761511) CBC panel - Blood by Automated count

4026

39385

1.10

2.21

19.8

17.5

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

748

0.67

2.20

4.6

iu/ml

1109.9

3867.1

—

110

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

475

5379

0.87

2.19

1.3

1.2

u/ml

9.2

15.4

1.30

170

1827

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

829

0.68

2.18

1.0

1.3

u/l

30.3

40.9

0.35

716

(3051387) C reactive protein [Mass/volume] in Capillary blood

132

1026

1.29

2.17

4.2

3.7

mg/l

24.5

31.0

1.53

676

(1617658) Protocol used for examination of sentinel lymph nodes

254

0.43

2.15

1.0

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.00

2.14

1.2

1.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

236

1964

1.21

2.14

3.6

4.1

mmol/l

25.4

24.8

2.99

203

1778

(3019225) pH of Specimen

554

4938

1.14

2.13

4.0

4.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

282

1.57

2.13

1.7

1.6

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

140

1101

1.28

2.11

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

668

0.66

2.10

1.0

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

102

1.96

2.10

1.1

—

(40768795) Lymph node Pathology biopsy report

396

0.55

2.09

1.0

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

710

1.34

2.07

1.1

—

(3012441) Differential panel - Pleural fluid

676

0.66

2.05

1.5

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2385

22870

1.08

2.04

4.1

6.2

umol/l

11.6

12.4

2.46

2231

21637

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

863

0.70

2.03

1.3

1.2

u/ml

2.2

5.9

1.92

133

(3014765) Yersinia sp identified in Stool by Organism specific culture

140

1109

1.27

2.01

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

907

0.71

2.00

1.2

u/ml

64.4

43.5

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.82

2.00

2.0

1.8

umol/l

13.5

18.7

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.96

1.99

1.0

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

177

1443

1.23

1.98

6.6

4.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

501

0.62

1.97

1.1

1.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

244

0.45

1.97

2.0

2.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

118

1505

0.78

1.96

2.9

4.0

u/ml

81.3

80.2

0.01

112

1437

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

236

1983

1.20

1.96

2.0

2.3

g/l

9.9

10.3

0.73

190

1641

(42529406) Shigella sp [Presence] in Stool by Culture

140

1114

1.26

1.95

1.2

—

(3045414) Leukocytes [Presence] in Urine

225

1886

1.20

1.92

2.2

2.0

—

(4198724)

2.57

1.92

1.5

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

189

0.42

1.91

1.0

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

852

0.71

1.90

1.3

1.2

u/ml

2.8

3.6

—

(40761536) Microorganisms panel - Urine sediment

399

3510

1.15

1.89

5.9

4.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

280

0.50

1.89

1.1

1.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

531

0.64

1.88

2.6

3.7

62.6

58.3

0.38

321

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

114

1.85

1.86

1.2

1.6

pmol/l

13.7

15.8

1.77

(40768441) Liver Pathology biopsy report

265

0.49

1.86

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

540

0.65

1.84

1.0

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

237

0.46

1.84

1.0

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

250

0.48

1.83

1.6

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3722

38027

0.92

1.81

4.9

5.3

mmol/l

6.0

6.1

7.12

3262

33603

(3002179) Metamyelocytes/100 leukocytes in Blood

286

3310

0.86

1.81

2.7

3.8

0.8

0.7

0.29

797

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

212

1781

1.20

1.79

2.1

2.4

g/l

0.6

1.1

2.10

173

1491

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

620

0.67

1.79

1.1

1.3

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

153

1.70

1.79

2.3

2.1

umol/l

44.5

54.5

1.25

120

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

176

1.65

1.79

1.1

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

436

3877

1.14

1.78

2.2

2.4

u/l

50.0

38.9

0.44

364

3292

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

169

1.66

1.76

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

246

0.49

1.76

1.2

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

246

0.49

1.76

1.2

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

246

0.49

1.76

1.2

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

246

0.49

1.76

1.2

1.6

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1138

10650

1.09

1.75

2.3

2.5

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.44

1.75

1.1

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.50

1.74

1.0

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

172

1422

1.22

1.73

2.3

g/l

0.0

0.00

152

1294

(3014051) Protein [Presence] in Urine by Test strip

126

1007

1.26

1.73

2.6

2.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

555

0.66

1.72

2.9

4.3

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

3.85

1.71

1.4

1.1

—

(3042631) Mycobacterium sp identified in Specimen

753

0.71

1.70

2.4

2.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

308

3521

0.87

1.67

1.4

1.5

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

243

1.53

1.67

2.3

1.8

u/field

1.2

2.4

1.43

169

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

491

0.65

1.67

1.0

1.1

u/ml

277.6

302.5

0.22

290

(3017181) Myelocytes/100 leukocytes in Blood

323

3676

0.87

1.65

2.9

3.9

0.8

1.0

0.69

1131

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

303

3463

0.87

1.65

1.5

—

(3000034) Microalbumin [Mass/volume] in Urine

440

0.63

1.63

3.1

3.2

mg/l

57.5

33.3

0.51

336

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

418

3730

1.13

1.63

2.8

3.7

ng/l

81.7

98.8

3.59

336

3124

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

164

1970

0.83

1.63

2.4

2.8

u/ml

0.4

0.3

1.26

1132

(3044927) Protein electrophoresis panel - Urine

591

1.32

1.62

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

508

5611

0.89

1.61

4.4

4.9

34.4

33.5

1.08

325

3580

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

557

0.68

1.60

1.8

1.5

56.9

63.5

0.51

354

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

111

1385

0.80

1.59

1.8

1.7

—

(3025941) Bacteria identified in Stool by Culture

229

1961

1.18

1.59

1.4

1.3

—

(3011412) CD3 cells [#/volume] in Blood

338

0.59

1.58

1.8

1.9

e9/l

1.0

1.1

0.16

205

(3045142) Bone marrow Pathology biopsy report

554

0.68

1.56

1.0

1.3

—

(3004451) EKG impression Narrative

272

1.47

1.55

1.4

1.3

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

157

0.45

1.54

1.6

4.7

13.5

13.4

—

157

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

173

1451

1.20

1.53

2.3

2.2

g/l

0.0

0.50

152

1300

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

244

2108

1.17

1.53

2.0

2.3

g/l

3.7

3.8

0.81

171

1475

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

365

1.40

1.52

1.3

1.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

731

6752

1.10

1.52

2.3

2.7

21.2

21.6

0.36

580

5663

(3030313) Adrenal Ab [Titer] in Serum

3.34

1.52

1.0

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

183

1545

1.19

1.51

2.2

2.3

g/l

0.1

0.0

0.31

162

1389

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.59

1.51

1.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

918

0.76

1.51

1.3

1.5

—

(3040151) Glucose [Moles/volume] in Capillary blood

607

1.31

1.51

11.0

19.0

mmol/l

7.2

7.5

0.41

500

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

244

2112

1.16

1.50

2.0

2.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

120

973

1.24

1.49

1.2

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

234

1.50

1.49

1.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

244

2114

1.16

1.48

2.0

2.3

g/l

7.0

7.5

3.47

172

1530

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

287

3262

0.87

1.47

1.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

226

1949

1.17

1.46

2.0

2.3

g/l

3.0

3.1

0.50

173

1507

(3009445) Proteinase 3 Ab [Units/volume] in Serum

163

1935

0.84

1.45

1.8

1.6

u/ml

23.1

21.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.37

1.45

1.1

1.0

—

(3021440) Promyelocytes/100 leukocytes in Blood

309

3491

0.88

1.45

3.0

3.9

0.2

0.1

0.37

1058

(3021901) Oxygen saturation in Capillary blood

125

1022

1.23

1.45

2.4

2.8

—

(3000991) Gas panel - Venous blood

458

4146

1.11

1.43

5.6

7.3

—

(3010421) pH of Blood

155

1297

1.20

1.43

4.2

4.7

7.4

0.00

130

1101

(3024263) Appearance of Synovial fluid

253

1.47

1.42

1.8

1.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

371

1.38

1.41

1.3

1.4

—

(3003181) Sodium [Moles/volume] in Urine

110

891

1.24

1.40

1.2

1.3

mmol/l

74.3

61.8

2.37

720

(3020491) Glucose [Moles/volume] in Blood

313

1.41

1.38

2.2

2.3

mmol/l

8.0

7.0

0.79

212

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.20

1.37

1.7

1.5

—

(3022145) Colonoscopy Study observation

404

4472

0.90

1.36

1.3

—

(3005033) Fetal Nuchal fold Thickness US

0.00

1.34

0.0

1.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

1.34

0.0

1.3

—

(3012501) Base excess in Blood by calculation

135

1123

1.21

1.34

4.4

4.8

mmol/l

2.6

2.7

0.29

101

773

(3019977) pH of Arterial blood

307

1.40

1.33

3.3

2.4

7.4

0.06

111

(3013290) Carbon dioxide [Partial pressure] in Blood

135

1124

1.21

1.33

4.4

4.8

kpa

5.1

5.0

0.72

130

1099

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

843

0.77

1.33

1.3

1.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

1.32

0.0

1.5

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1074

0.80

1.30

2.3

3.2

u/ml

192.7

845.6

1.44

984

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

145

1.59

1.28

2.3

2.7

umol/l

25.8

29.0

0.46

108

(3022313) Gas panel - Capillary blood

264

2330

1.14

1.28

3.3

3.9

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

530

4867

1.10

1.28

3.2

3.1

ng/l

214.2

253.0

1.39

480

4485

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2345

22724

1.06

1.27

3.1

3.2

u/l

45.2

57.9

6.42

2109

20403

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

192

0.52

1.27

1.4

1.7

—

(1616796) Gas panel - Central venous blood

136

1141

1.20

1.25

3.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

191

0.52

1.25

1.2

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

191

0.52

1.25

1.2

1.7

—

(3027315) Oxygen [Partial pressure] in Blood

135

1132

1.20

1.25

4.4

4.9

kpa

8.3

0.06

129

1107

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

800

0.77

1.23

1.5

1.6

mg/l

2.2

3.7

1.06

592

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

187

1.50

1.23

1.5

1.8

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

552

5978

0.91

1.22

2.6

4.0

u/l

233.9

245.9

1.59

509

5594

(3025159) Blasts/100 leukocytes in Blood

289

3237

0.89

1.22

3.0

4.0

1.7

0.3

0.42

880

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

409

0.68

1.22

1.0

1.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

249

2812

0.88

1.20

2.7

2.8

g/l

10.1

10.7

1.16

214

2534

(3013166) Neutrophils/100 leukocytes in Synovial fluid

148

1.56

1.19

1.4

1.3

64.0

64.1

0.00

124

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1956

18884

1.06

1.19

5.0

5.6

ug/l

4.9

4.3

0.20

1725

16644

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

383

0.68

1.19

1.3

1.2

mmol/l

7.3

7.8

0.44

268

(3023520) Reticulocytes [#/volume] in Blood

523

4819

1.09

1.19

1.9

2.4

e9/l

62.5

67.9

3.69

407

3684

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

296

2647

1.13

1.18

2.5

2.6

—

(21494890) Protein electrophoresis panel - 24 hour Urine

580

0.74

1.18

1.3

2.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

406

0.69

1.18

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

441

0.70

1.18

1.2

u/ml

2.6

3.6

0.28

132

(40758558) Short blood count panel - Blood

1087

10315

1.07

1.16

4.9

6.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1576

15130

1.06

1.16

4.6

4.8

22.0

22.1

0.09

825

8224

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

668

1.25

1.16

5.6

6.2

mg/l

12.3

0.05

614

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

120

1005

1.20

1.15

1.3

1.4

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

118

1.61

1.14

1.6

1.5

ug/l

0.3

0.4

0.37

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

306

2749

1.12

1.14

7.1

9.0

—

(36660697) Celiac disease serology panel - Serum

283

2532

1.12

1.13

1.2

—

(3002256) Pathology report gross observation

521

5633

0.92

1.13

1.3

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

532

5743

0.92

1.11

1.3

iu/ml

31.6

40.5

0.75

133

1763

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

539

1.27

1.09

1.6

1.8

pmol/l

191.5

198.5

0.20

496

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

1.95

1.08

1.5

1.0

—

16.9

—

(3048879) Bone marrow aspiration report

163

0.55

1.08

1.1

1.5

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

326

0.67

1.06

1.2

1.1

—

86.8

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.92

1.06

1.0

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

145

1.52

1.05

1.0

1.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.12

1.05

1.4

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

476

0.73

1.04

1.1

g/l

1.5

1.6

0.73

425

(3038026) Centromere Ab [Units/volume] in Serum

336

0.68

1.03

1.3

1.1

—

70.6

—

(3028626) Oxygen [Partial pressure] in Capillary blood

139

1193

1.17

1.03

2.3

2.9

kpa

8.0

7.8

0.83

134

1093

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

148

0.54

1.03

1.9

2.0

u/l

15.0

55.2

—

137

(3004716) Salmonella sp identified in Stool by Organism specific culture

157

1361

1.16

1.03

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.77

1.00

1.2

1.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

831

7859

1.07

1.00

4.0

4.7

—

(40767503) Oxygen content in Capillary blood by calculation

130

1114

1.17

0.99

2.9

2.5

16.2

15.9

0.41

578

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1037

0.83

0.99

1.4

1.6

iu/ml

0.5

13.8

1.20

244

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

765

1.21

0.98

1.8

1.7

—

(3020779) Urea [Moles/volume] in Serum or Plasma

428

4634

0.92

0.98

4.9

6.7

mmol/l

10.8

11.4

0.90

385

4369

(3028308) Erythrocytes [#/volume] in Pleural fluid

706

0.79

0.98

1.5

e6/l

99270.3

71252.1

0.38

416

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

594

0.77

0.97

1.1

1.2

—

40.7

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

0.00

0.97

0.0

1.1

—

1.8

—

(3048689) Calprotectin [Mass/mass] in Stool

404

3719

1.09

0.97

1.9

2.0

ug/g

217.2

169.3

1.21

322

2847

(3023199) Leukocytes [#/volume] in Pleural fluid

771

0.80

0.97

1.5

e6/l

1729.6

1687.7

0.03

561

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.00

0.96

0.0

1.2

—

3341.6

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

525

0.76

0.96

1.1

1.4

u/ml

114.1

126.4

—

110

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

422

0.73

0.95

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

410

0.73

0.94

1.1

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

410

0.73

0.94

1.1

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

410

0.73

0.94

1.1

1.5

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

705

1.21

0.94

1.4

1.3

—

(40768806) Pleura Pathology biopsy report

680

0.79

0.94

1.6

—

(3004775) Volume in Urine collected for unspecified duration

398

0.73

0.94

2.2

581.8

652.4

0.46

236

(3017569) Oxygen content in Arterial blood

277

1.34

0.93

3.3

2.0

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

158

1.46

0.93

3.0

5.7

76.7

72.6

0.34

125

(3052592) Norovirus Ag [Presence] in Stool

109

1.56

0.93

1.4

—

(3047189) Immunofixation for 24 hour Urine

269

0.67

0.93

1.2

1.6

—

(3017732) Neutrophils [#/volume] in Blood

287

2607

1.11

0.92

2.7

3.3

e9/l

4.3

4.2

0.09

180

1823

(40768797) Stomach Pathology biopsy report

608

5707

1.07

0.92

1.2

1.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

196

0.61

0.92

1.2

1.1

—

(3016038) Potassium [Moles/volume] in Urine

313

1.31

0.91

1.2

1.1

mmol/l

36.4

35.0

0.21

264

(3017704) Immunofixation for Urine

326

0.70

0.91

1.2

1.5

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

482

1.25

0.90

1.9

1.7

mu/l

204.8

304.4

4.47

441

(3028707) Methadone [Presence] in Urine by Screen method

118

1.53

0.90

1.4

1.6

—

(3002385) Erythrocyte distribution width [Ratio]

3115

30579

1.05

0.90

24.1

21.9

13.8

14.0

10.18

3039

29782

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

519

0.77

0.90

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.07

0.89

1.0

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

253

0.67

0.87

1.8

1.9

12.0

14.6

—

(4268621)

288

0.69

0.87

2.3

—

(3016750) Collection duration of Urine

275

0.69

0.85

2.2

2.0

min

505.6

492.1

0.24

187

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

705

1.19

0.85

1.3

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

458

0.76

0.85

1.0

1.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

257

2334

1.11

0.85

2.7

3.7

mmol/l

25.1

24.1

4.82

216

2078

(3007461) Platelets [#/volume] in Blood

4230

41870

1.06

0.84

29.6

26.5

e9/l

237.6

238.4

0.37

4106

40470

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

250

0.68

0.83

1.8

1.9

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

166

0.60

0.83

1.3

1.4

33.6

22.5

—

135

(3035941) MCH [Entitic mass]

4230

41873

1.06

0.83

29.5

26.4

30.4

30.5

0.75

4146

40974

(3024731) MCV [Entitic volume]

4230

41874

1.06

0.82

29.5

26.4

91.9

91.8

0.20

4146

40975

(3026361) Erythrocytes [#/volume] in Blood

4230

41875

1.06

0.82

29.6

26.5

e12/l

4.3

4.4

18.12

4083

40304

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

765

0.82

1.3

1.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1131

0.85

0.81

1.3

1.5

—

(3000963) Hemoglobin [Mass/volume] in Blood

4230

41883

1.06

0.80

29.8

26.7

g/l

129.8

132.6

28.18

4150

40998

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

397

0.75

0.80

1.0

1.3

miu/ml

195.4

184.8

—

111

(3042936) Bacteria identified in Isolate by Culture

681

6454

1.06

0.79

2.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

294

1.29

0.79

1.1

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

641

0.81

0.79

1.2

1.4

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

304

2796

1.09

0.79

4.7

6.6

mmol/l

25.1

24.8

0.50

299

2771

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1085

0.85

0.79

1.3

1.5

—

(3024316) Viscosity of Plasma

0.00

0.78

0.0

1.5

—

1.6

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1027

10697

0.95

0.78

3.0

3.3

ug/l

0.7

0.8

2.64

748

7846

(3028679) Herpes simplex virus Ab [Presence] in Serum

123

1.47

0.77

1.1

—

(3010813) Leukocytes [#/volume] in Blood

4229

41884

1.05

0.77

29.6

26.5

e9/l

6.8

7.0

2.16

4085

40305

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

676

1.19

0.77

1.8

2.1

mg/l

21.8

26.0

0.32

151

(3034426) Prothrombin time (PT)

100

0.50

0.77

1.4

1.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

767

0.83

0.75

1.2

1.4

nmol/l

0.7

0.8

0.82

625

(3024139) IgG subclass 3 [Mass/volume] in Serum

324

0.74

1.4

1.3

g/l

0.3

0.4

1.08

227

(3027135) IgG subclass 1 [Mass/volume] in Serum

324

0.74

1.4

1.3

g/l

7.6

7.0

0.24

226

(3028192) IgG subclass 2 [Mass/volume] in Serum

324

0.74

1.4

1.3

g/l

1.9

2.9

2.74

229

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

1.84

0.73

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

134

0.60

0.73

1.0

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

442

1.22

0.73

1.3

e6/l

142906.4

109169.1

0.12

303

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.80

0.72

1.0

1.2

u/l

30.3

12.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

183

0.65

0.72

1.2

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

183

0.65

0.72

1.2

1.0

—

(3004616) Nuclear Ab [Presence] in Serum

467

0.79

0.71

1.4

1.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

148

1320

1.12

0.71

1.4

1.6

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

182

0.66

0.70

1.2

mmol/l

5.8

6.2

0.85

172

(3000570) Elastase.pancreatic [Mass/mass] in Stool

146

1302

1.12

0.70

1.5

ug/g

259.6

261.5

0.04

791

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

283

2613

1.09

0.69

1.5

1.7

g/l

1.5

1.6

0.05

239

2232

(3027456) Digoxin [Moles/volume] in Serum or Plasma

120

1358

0.88

0.69

3.3

3.1

nmol/l

0.8

1.12

1016

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

1.51

0.69

1.3

g/l

0.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

228

0.70

0.69

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

228

0.70

0.69

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

228

0.70

0.69

1.1

—

(3011648) Oxygen content in Venous blood

342

0.76

0.69

1.4

1.7

9.9

10.7

0.32

342

(3043410) Blood group antigens tested for on Red Blood Cells

135

1.41

0.68

1.4

2.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.85

0.68

1.2

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

419

1.22

0.68

1.6

1.7

u/ml

25.6

26.7

0.08

(40768443) Skin Pathology biopsy report

176

1944

0.90

0.67

1.2

—

(4146454)

572

0.82

0.66

3.2

2.7

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

0.53

0.66

1.2

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.51

0.66

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

225

0.71

0.65

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

225

0.71

0.65

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

225

0.71

0.65

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

293

0.75

0.64

1.5

—

(3000494) Fungus identified in Specimen by Culture

497

4705

1.06

0.63

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

103

906

1.14

0.63

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

292

0.75

0.63

1.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

129

1.40

0.63

1.2

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

181

1.33

0.63

1.5

g/l

0.9

0.43

181

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

425

0.80

0.62

1.2

u/ml

2.5

5.2

1.99

191

(3000285) Sodium [Moles/volume] in Blood

1.52

0.62

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

986

0.87

0.62

2.6

2.4

184.2

209.1

2.11

939

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

315

1.24

0.62

1.1

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

985

0.87

0.61

1.5

1.8

mg/l

10.2

12.7

2.09

891

(44806071)

1.67

0.61

1.0

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

253

1.27

0.61

1.3

promille

0.6

1.0

1.27

192

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

0.60

0.0

1.8

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.60

0.0

1.8

—

1.5

—

(40758358) Immune stain study

0.00

0.60

0.0

1.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

543

0.83

0.60

4.1

3.5

—

(3016228) CD19 cells/100 cells in Blood

151

0.66

0.59

2.0

1.8

2.8

7.3

—

143

(3035880) pH of Pleural fluid

355

0.79

0.59

1.4

1.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

453

4781

0.94

0.59

2.2

2.6

umol/l

8.3

9.8

0.82

401

4159

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

114

1.40

0.58

1.5

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

3349

33081

1.04

0.58

22.5

19.6

37.0

38.2

6.01

1896

19787

(3024980) IgG subclass 4 [Mass/volume] in Serum

529

0.83

0.57

2.2

1.6

g/l

0.6

0.9

2.08

397

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

196

0.71

0.57

1.3

ug/l

1.6

563.4

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

1.67

0.56

4.2

2.4

mg/l

1.1

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

0.57

0.56

1.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

635

0.85

0.56

1.2

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.56

1.2

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

590

0.85

0.54

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

250

0.76

0.53

1.5

3.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

513

0.84

0.53

1.1

1.3

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

158

0.70

0.52

5.2

4.6

—

62.6

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1108

0.89

0.52

2.1

2.2

g/l

3.4

3.6

0.79

1048

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

143

1.33

0.52

1.0

1.2

—

(4062490)

326

0.80

0.51

1.3

—

(3037121) Protein [Mass/volume] in Urine

180

1662

1.09

0.49

2.3

3.0

g/l

0.2

0.3

4.21

683

(3016330) Potassium [Moles/time] in 24 hour Urine

1.56

0.49

1.4

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

344

1.19

0.48

1.3

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

126

1384

0.91

0.48

1.7

3.4

—

(3028271) Lactate [Moles/volume] in Capillary blood

822

1.12

0.48

2.4

1.9

mmol/l

1.7

0.04

800

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

285

2681

1.07

0.48

6.1

8.2

mmol/l

24.7

24.3

1.47

263

2454

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1017

0.89

0.48

1.4

g/l

0.2

1.78

959

(3022689) Creatine [Moles/volume] in Urine

110

0.64

0.48

1.6

1.5

—

(3005322) IgE [Units/volume] in Serum or Plasma

163

1768

0.92

0.48

1.3

u/ml

492.9

228.9

0.55

143

1603

(3045683) HLA typing for celiac disease panel - Blood or Tissue

119

1.35

0.48

1.0

—

(21494814) CD8 cells/100 lymphocytes in Specimen

143

0.70

0.47

2.0

1.9

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

1.49

0.47

1.1

u/ml

—

0.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

177

0.73

0.47

1.2

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

233

0.77

0.47

1.0

u/ml

1.0

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

332

0.81

0.46

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.43

0.46

4.4

2.5

u/field

0.7

0.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.38

0.46

1.2

1.1

miu/ml

2544.0

1643.0

1.22

(3025577) Chromium [Mass/volume] in Blood

342

0.82

0.45

2.1

2.0

ug/l

2.1

0.00

287

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

120

0.67

0.45

1.6

2.7

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

120

0.67

0.45

1.4

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.59

0.45

1.4

1.1

—

(3001729) Color of Synovial fluid

1.40

0.45

1.3

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

810

0.89

0.44

2.5

3.6

57.3

59.1

0.66

810

(4212803)

1.37

0.44

1.0

1.1

—

(3021589) Normoblasts [#/volume] in Blood

1785

17525

1.03

0.43

10.8

10.5

e9/l

0.0

0.04

1432

14168

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

127

0.71

0.43

2.1

1.8

—

(3021788) Differential panel - Synovial fluid

798

0.89

0.43

1.6

1.5

—

(40768446) Kidney Pathology biopsy report

130

0.69

0.43

1.7

1.5

—

(3037756) Immunofixation for Serum or Plasma

112

1227

0.91

0.43

1.3

1.6

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

368

1.17

0.42

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.56

0.42

1.0

1.5

—

(3020393) Adenovirus Ag [Presence] in Stool

1.56

0.42

1.0

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1048

0.90

0.42

2.0

2.1

94.0

87.7

2.02

1002

(3035320) C reactive protein [Mass/volume] in Body fluid

304

1.19

0.41

2.8

2.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

158

1.27

0.41

1.8

2.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

158

1.27

0.41

1.8

2.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

519

1.14

0.41

2.8

3.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

604

1.13

0.41

1.3

1.4

—

(3010838) Calcium [Moles/time] in 24 hour Urine

206

0.78

0.41

1.8

—

9.3

—

(3049242) von Willebrand panel - Platelet poor plasma

0.00

0.41

0.0

2.2

—

(3022806) Fractional oxyhemoglobin in Capillary blood

671

1.12

0.41

2.4

1.9

89.3

88.9

0.30

662

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.47

0.40

1.0

1.1

—

(3024928) Oxygen saturation in Venous blood

111

1016

1.09

0.40

1.7

2.7

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

0.40

0.0

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

597

1.12

0.39

1.3

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.31

0.39

1.1

1.2

—

(3008295) Osmolality of Serum or Plasma

456

1.14

0.39

1.3

mosm/kgh2o

276.7

0.00

334

(3023383) Lactate [Moles/volume] in Pleural fluid

193

0.78

0.39

1.2

1.3

mmol/l

5.1

3.2

1.10

173

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

541

1.13

0.39

1.4

1.3

nmol/l

0.8

0.2

3.35

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

147

1582

0.93

0.39

1.4

1.7

u/l

36.6

37.9

0.36

123

1334

(3015235) Bicarbonate [Moles/volume] in Capillary blood

150

1394

1.08

0.38

2.5

3.1

mmol/l

25.4

25.0

0.47

140

1197

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

442

0.86

0.38

1.5

u/l

12.6

13.3

0.30

420

(3037692) Legionella sp identified in Specimen by Organism specific culture

159

0.75

0.38

1.0

1.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

236

0.80

0.38

1.0

u/ml

1.1

3.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

486

1.13

0.37

1.4

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

600

1.12

0.37

1.3

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

600

1.12

0.37

1.3

1.4

—

(3044889) 12 lead EKG panel

2906

28759

1.02

0.37

4.3

4.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

546

0.88

0.37

1.4

1.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

468

1.13

0.36

1.2

1.5

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

535

0.88

0.36

4.3

3.3

nmol/l

4.9

8.2

1.02

523

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

651

0.89

0.36

1.3

1.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

244

1.19

0.36

1.1

—

(3002619) Bacteria identified in Specimen by Culture

1.36

0.36

1.4

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

713

0.90

0.36

1.5

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

602

1.11

0.35

1.3

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

119

1101

1.08

0.35

1.7

1.6

e6/l

13378.5

15967.5

0.29

782

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

612

1.11

0.35

1.3

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

154

1441

1.07

0.34

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

585

0.89

0.34

1.6

1.7

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

669

0.90

0.34

1.3

1.5

—

(3013512) EKG study

1411

13858

1.03

0.34

4.8

4.5

—

(3045788) Cell count panel - Pleural fluid

594

0.89

0.33

1.5

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

155

0.77

0.33

1.0

1.4

umol/l

23.7

19.8

0.17

147

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

530

0.89

0.33

1.0

1.1

iu/ml

25.6

379.6

0.55

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

131

1222

1.07

0.33

1.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

638

6199

1.03

0.32

1.3

1.5

g/l

2.5

2.7

1.20

306

3490

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

392

0.87

0.32

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

0.67

0.32

1.0

1.1

—

4.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

492

1.12

0.32

1.1

—

(21494434) Karyotype in Bone marrow

455

0.88

0.32

1.0

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

192

1.20

0.32

5.7

6.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

176

1861

0.94

0.30

2.6

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

0.71

0.30

1.0

1.5

—

1930910.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

272

0.84

0.30

1.1

u/ml

0.3

1.8

—

101

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

268

1.16

0.30

4.4

4.8

u/ml

44.9

53.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1046

0.93

0.30

1.4

1.5

g/l

1.1

1.2

0.41

984

(3045424) Erythrocytes [Presence] in Urine

706

1.09

0.30

1.4

1.5

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

113

1209

0.93

0.29

2.2

2.3

ug/min

142.0

93.8

0.66

697

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

204

1.18

0.28

1.3

—

(44813793)

184

0.81

0.28

1.1

1.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

291

0.86

0.28

2.8

3.6

—

(3011985) Renin [Units/volume] in Plasma

536

1.10

0.28

1.3

1.4

mu/l

27.2

64.4

3.03

468

(3001019) Free T4 and TSH panel - Serum or Plasma

632

1.09

0.28

2.1

1.8

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

270

1.15

0.28

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

270

1.15

0.28

1.3

1.4

—

(3045716) Anion gap in Serum or Plasma

242

1.16

0.28

1.3

2.1

mmol/l

7.6

9.3

1.61

195

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

384

1.12

0.27

1.0

1.1

—

12.2

—

(3049717) Cytology report of Urine Cyto stain

239

2288

1.05

0.27

2.4

2.9

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.25

0.27

1.0

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

647

6312

1.03

0.27

4.2

5.6

mmol/l

1.0

2.52

585

5783

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1061

0.93

0.27

1.4

1.6

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

131

1.22

0.27

1.7

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

529

1.10

0.26

1.2

1.3

u/l

10.1

10.3

0.04

420

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.26

0.26

1.3

1.4

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.28

0.26

1.3

1.6

ng/l

79.1

147.8

2.31

(3042733) HLA Ab [Presence] in Serum

0.70

0.26

4.0

5.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

272

1.14

0.26

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

472

1.10

0.26

1.5

1.3

nmol/l

—

(3051611) Lipemic interference index of Serum or Plasma

520

1.10

0.25

3.1

3.4

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1230

12109

1.02

0.25

2.7

3.2

u/l

30.1

37.9

3.03

1145

11360

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

1.23

0.25

1.6

1.4

66.3

73.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

358

1.12

0.25

1.5

1.3

iu/l

37.2

30.5

0.48

294

(4211845)

235

1.15

0.25

3.0

4.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

167

1752

0.95

0.24

1.2

iu/ml

82.5

124.3

0.75

588

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.26

0.24

1.3

63.3

80.6

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.28

0.24

1.0

1.5

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

161

1.18

0.24

2.7

2.8

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

0.71

0.24

1.2

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

169

0.83

0.23

1.4

1.2

g/l

41.2

39.8

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4061

40782

0.98

0.23

9.9

11.5

u/l

18.3

25.1

99.83

3782

38875

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

746

1.07

0.23

2.7

3.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

168

0.83

0.22

1.9

2.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

134

1273

1.05

0.22

1.1

1.2

u/ml

1.4

1.1

0.10

122

(3014891) Appearance of Pleural fluid

0.76

0.22

1.7

1.5

—

(3006462) Nitrate [Presence] in Urine

219

1.14

0.22

3.2

4.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.22

0.22

1.0

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

124

0.81

0.21

1.0

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

315

0.89

0.21

9.0

14.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

720

0.93

0.21

1.2

1.4

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.0

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

0.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.0

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.21

0.0

12.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

103

0.78

0.21

1.1

1.5

umol/l

1.9

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.16

0.21

1.2

1.7

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.3

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.2

—

7.8

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.21

0.0

1.2

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.21

0.0

1.6

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.20

0.0

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.21

0.18

1.0

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

290

1.10

0.18

3.2

1.9

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

271

1.11

0.18

1.3

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

271

1.11

0.18

1.3

1.4

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.13

0.17

1.0

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

455

1.08

0.17

1.1

1.6

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

110

1.18

0.17

1.0

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

0.76

0.17

1.2

mg/l

7.4

8.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

205

1.12

0.17

1.0

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

0.74

0.17

1.0

1.3

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.16

0.16

1.0

1.3

—

(3025130) Human papilloma virus identified in Specimen

183

0.87

0.16

1.9

1.6

—

(3044941) Cell count panel - Synovial fluid

710

1.06

0.16

1.5

1.4

—

(3024932) HLA-DR beta [Type]

0.78

0.15

1.3

1.1

—

(3024471) HLA-A [Type]

0.76

0.15

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.11

0.15

1.0

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

131

1.15

0.14

1.1

1.2

—

(44806420)

181

0.88

0.14

2.8

2.4

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

353

1.08

0.14

1.3

1.4

titre

251.3

167.9

—

(3026389) Candida sp identified in Specimen by Organism specific culture

531

0.94

0.13

1.3

1.4

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

417

0.93

0.13

1.7

1.4

24.3

25.0

0.04

262

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

384

1.07

0.12

1.4

—

(3008898) HLA-B27 [Presence]

698

1.05

0.12

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

158

0.89

0.12

1.5

—

(4306422)

385

0.93

0.12

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

114

1.14

0.11

1.2

1.1

—

(3023419) Bacteria identified in Sputum by Culture

640

0.95

0.11

2.2

2.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

256

2507

1.02

0.11

1.2

—

(3036603) Volume of Urine

292

0.92

0.11

1.2

1.7

1755.9

1766.6

—

(3002523) Influenza virus A Ag [Presence] in Specimen

240

0.92

0.11

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

134

1.12

0.10

1.1

1.4

umol/l

44.2

93.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

280

0.93

0.10

1.2

titre

55.0

131.7

—

(3027944) Amphetamines [Presence] in Urine

218

0.92

0.10

1.5

1.4

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

251

1.08

0.10

1.4

1.2

u/l

20.8

26.1

0.34

209

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

433

0.95

0.10

1.1

1.6

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

122

1254

0.97

0.09

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

290

2853

1.02

0.09

1.9

2.1

nmol/l

12.1

11.8

0.29

249

2418

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

431

0.95

0.09

1.4

1.6

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

498

1.04

0.08

1.2

1.3

pmol/l

227.5

261.5

0.57

369

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.03

0.08

3.2

1.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

175

1.09

0.08

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

263

1.06

0.08

1.8

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

0.79

0.08

2.6

3.4

umol/l

26.3

41.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.86

0.07

1.0

1.3

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

441

1.04

0.07

1.3

1.2

u/l

76.8

61.9

0.47

294

(4133840)

1.08

0.07

1.0

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

225

0.93

0.07

1.0

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.83

0.07

1.0

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

818

1.03

0.07

1.6

1.4

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

0.89

0.06

1.1

1.2

—

84.0

—

(3027008) Opiates [Presence] in Urine

224

0.94

0.06

1.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

180

1829

0.98

0.06

1.8

3.3

mg/l

52.6

91.6

0.67

145

1504

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.11

0.06

1.0

1.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

101

0.89

0.06

1.3

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

148

1.08

0.06

1.3

1.2

—

(44790049)

466

0.97

0.05

1.1

1.4

—

(44790048)

466

0.97

0.05

1.1

1.4

—

(44806118)

466

0.97

0.05

1.1

1.4

—

(44790047)

466

0.97

0.05

1.1

1.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

180

1826

0.99

0.05

1.8

3.3

mg/l

34.6

57.0

1.82

144

1504

(3028433) Virus identified in Specimen by Culture

141

0.92

0.05

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

208

1.06

0.05

1.2

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

788

0.98

0.05

1.2

1.4

—

(3016879) Cocaine [Presence] in Urine

212

0.94

0.05

1.5

1.4

—

(40757373) Influenza virus identified in Isolate

110

0.91

0.05

1.2

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

209

1.05

0.04

1.2

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

160

1.06

0.04

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

756

1.02

0.03

1.4

1.7

iu/l

4.5

4.4

0.03

219

(3003740) Influenza virus B Ag [Presence] in Specimen

240

0.96

0.03

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

346

3438

1.01

0.03

3.3

2.8

ml/min/173m2

64.7

59.4

1.37

117

1495

(3038177) Helicobacter pylori Ab [Presence] in Serum

431

0.97

0.03

1.5

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

948

1.01

0.02

1.9

1.6

—

(40765096) Chromosome analysis panel by Banding

148

0.95

0.02

1.3

1.1

—

(4094501)

103

1042

0.99

0.02

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

262

1.03

0.02

1.4

1.2

u/l

81.3

96.3

0.46

222

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

268

0.97

0.02

1.8

1.6

u/l

3.0

7.5

1.34

126

(42529582) MDA5 Ab [Presence] in Serum by Line blot

103

1.07

0.02

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

103

1.07

0.02

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

103

1.07

0.02

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

103

1.07

0.02

1.0

1.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

127

0.94

0.01

1.3

2.1

115.5

180.1

3.32

115

(3022217) INR in Platelet poor plasma by Coagulation assay

750

7484

1.00

0.01

27.0

30.5

inr

1.4

1.5

1.04

1045

(3011288) Drugs identified in Urine by Screen method

153

1.05

0.01

2.6

1.9

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

293

2941

1.00

0.01

1.5

1.7

1.5

1.6

3.13

243

2412

(3035947) Staphylolysin Ab [Units/volume] in Serum

224

1.03

0.00

1.1

iu/ml

—

4.3

—

(3000012) Reticulocyte production index

294

1.02

0.00

1.3

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

316

0.98

0.00

1.2

1.1

u/ml

5.5

2.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

179

1784

1.00

0.00

1.8

3.2

ratio

1.4

3.7

—

136

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

432

4314

1.00

0.00

2.0

2.1

g/l

0.2

0.10

390

3972

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

132

0.98

0.00

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

192

0.99

0.00

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

215

1.02

0.00

1.1

u/l

75.0

88.3

0.43

160

(3028300) Cannabinoids [Presence] in Urine

225

0.98

0.00

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

335

0.98

0.00

1.3

1.5

—

(1002224) Polysomnography panel

845

0.99

0.00

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

114

0.96

0.00

1.7

2.4

—

(3051101) Glucose [Moles/volume] in Cord blood

1.03

0.00

4.4

6.1

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

1.03

0.00

1.4

2.2

140.9

215.6

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

204

0.98

0.00

1.1

4.3

mg/l

92.8

68.2

—

143

(3000764) Benzodiazepines [Presence] in Urine

223

0.99

0.00

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

111

0.99

0.00

1.0

1.7

—

(21491868) Cryoglobulin [Mass/volume] in Serum

139

1.01

0.00

1.1

1.3

g/l

—

0.2

—

(4015189)

149

1.01

0.00

1.8

1.9

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

169

1.01

0.00

1.4

pmol/l

141.5

62.6

—

(3036489) Thrombin time

140

1397

1.00

0.00

1.9

22.7

21.8

0.38

128

1271

(3051651) Icteric interference index of Serum or Plasma

279

1.00

0.00

3.1

3.5

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

0.0

1.0

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

0.00

0.0

1.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.2

—

3776.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.6

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

0.0

1.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3015183) Erythrocyte sedimentation rate

0.97

0.00

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.96

0.00

1.2

1.1

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.2

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.0

1.0

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

0.91

0.00

1.4

1.2

nmol/l

15.1

7.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

0.0

1.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

0.91

0.00

1.1

—

(3042517) Benzodiazepines panel - Urine

0.00

0.0

1.5

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.0

1.1

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

4.9

—

357.4

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.01

0.00

1.9

1.5

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.88

0.00

3.0

1.5

umol/l

23.2

45.3

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

2.5

—

2.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.99

0.00

1.0

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.96

0.00

1.0

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.0

3.6

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.0

1.7

—

(3032057) Clostridioides difficile [Presence] in Stool

130

1.00

0.00

2.0

1.8

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: PDMED_LEVODOPA_DECARBOXYLASEINHIBITOR – Use of levodopa decarboxylase inhibitor

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Use of levodopa decarboxylase inhibitor

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Case counts by code for Use of levodopa decarboxylase inhibitor (PDMED_LEVODOPA_DECARBOXYLASEINHIBITOR)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints